The platform connects patients with US-licensed healthcare providers who evaluate medical histories and, when clinically appropriate, may prescribe treatments aimed at supporting healthspan rather than simply treating diagnosed diseases
The first-dose experience with oral forms differs from injectable in terms of onset timing, bioavailability, and side effect profile
In some instances, the side effects were serious enough for patients to require medical treatment for symptoms such as nausea, vomiting, diarrhea, abdominal pain, and constipation, the FDA said
Looking specifically for GLP-1 weight loss
It soon became clear that the approach had wider applicability and appeal to anyone with a medical condition such as hypertension, AFib, heart failure or non diabetic hyperglycaemia with one or more of the following: waist circumference greater than half their height a strong indicator of elevated VAT unhealthy visceral fat on CT or body composition scan starting a lifestyle-based approach to reduce VAT, with or without medication overweight but not yet eligible or ready for GLP-1 mimetics, who want to measure progress with lifestyle and medical nutrition therapy
A1C testing offers a window into average blood sugar control spanning approximately three months